eujobs.coEU jobs in brussels
Post a JobHeadhunter

Eli Lilly and Company

Acronym: Lilly

General Information

Identification Code: 04657143399-39
Website: [object Object]
Entity Form: Corporation
Registration Category: Companies & groups
Registration Date: 4/2/2010
Last Update: 3/17/2024
EP Accredited Number: 6

Mission & Interests

Goals: Lilly is a leading innovative biopharmaceutical company that unites caring with discovery to make life better for people around the world. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. Headquartered in the US, Lilly has more than 42,978 employees worldwide. In 2023 global revenue was approx. $34.12 billion, of which 27.3% were invested in R&D. Average cost to discover and develop a new drug: $2.6 billion. Average length of time from discovery to patient: 10 years. ( https://investor.lilly.com/financials.cfm )
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
  • Budget
  • Business and industry
  • Climate action
  • Competition
  • Customs
  • Digital economy and society
  • Economy, finance and the euro
  • Education and training
  • Employment and social affairs
  • Energy
  • Environment
  • External relations
  • Food safety
  • Foreign affairs and security policy
  • Humanitarian aid and civil protection
  • Institutional affairs
  • Public health
  • Research and innovation
  • Single market
  • Taxation
  • Trade
Levels of Interest:
  • global

Activities

Main EU Legislative Proposals: EU Pharmaceutical Strategy, EU pharmaceutical legislation, Intellectual Property Rights and incentives - including Orphan Medicinal Products, Paediatric medicines and Anti-Microbial Resistance (AMR), Free Trade Agreements - EU/US, EU/UK, EU Beating Cancer Plan, EU HTA Regulation, EU Green Deal, Pharmaceuticals in the environment (PIE), the Circular Economy, Climate change, Energy taxes, European Chemicals Agency (ECA), Packaging and Packaging Waste Regulation, REACH, Urban Waste Water Treatment Directive, per-and polyfluoroalkyl substances (PFAS), Industrial strategy (including bio-manufacturing), Competition law, Horizon Europe, Innovative Healthcare Initiative (IHI), European Medicines Agency (EMA), Clinical Trials Regulation, Medical Devices Regulation, Falsified Medicines Directive, Cross-border Healthcare Directive, Data Protection Regulation, Public Procurement Directive, Substances of Human Origin (SoHO), Transparency Directive, Artificial intelligence, Digital / Digital health, European Health Data Space. Other policy areas of interest include Innovation, Research and Development, Public-Private Partnerships, Mergers and acquisitions, Life sciences, Biopharmaceuticals, Manufacturing including Active Pharmaceutical Ingredients (API), Health outcomes, Real world evidence, Pricing, reimbursement and market access to medicines, Alzheimer's research, cancer, diabetes, immunology, obesity, pain, healthcare sustainability, global health pandemics, clinical trials transparency, patient advocacy group payments, transfers of value to healthcare professionals and healthcare organisations.
Communication Activities: Represented through several trade bodies and industry associations, for example EFPIA, EuropaBio, AmChamEU. Participating in events on trade, industrial, health and life science policy, for example European Health Summit, Kangaroo Group and The Parliament magazine debates. Meeting with policy makers in the EU institutions. Engaging with other public policy stakeholders.
Inter-institutional or Unofficial Groupings: N/A

Head Office

Address: Lilly Corporate CenterIndianapolis
Post Code: 46285
City: Indianapolis
Country: UNITED STATES
Phone: [object Object]

EU Office

Address: Rue du Marquis 1/4B Markiesstraat
Post Code: B-1000
City: Brusselles / Brussel
Country: BELGIUM
Phone: [object Object]

Financial Data

New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]

Membership Information

Members10 Percent: 4
Members25 Percent: 0
Members50 Percent: 3
Members75 Percent: 0
Members: 7
Members F T E: 1.899999976158142
Info Members: Note: 3 colleagues are full-time engaged in the Brussels office and will spend approximately 30% - 50% of their time on relevant EU affairs, with another in the Brussels office and 4 outside the Brussels office. A few other colleagues whereas spend a fraction of their time (<5%).

Structure

Structure Type: Structure
Is Member Of: European Association of Pharmaceutical Industries and Associations (EFPIA), The European Association of Bioindustries (EuropaBio), American Chamber of Commerce to the European Union (AmChamEU), Kangaroo Group, European Business Summit, Pharmaceutical Research and Manufacturers of America (PhRMA), International Federation of Pharmaceutical Manufacturers and Associations (IFPMA).
Organisation Members: Eli Lilly and Company is a member of the following associations and bodies: European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Association of Bioindustries (EuropaBio), American Chamber of Commerce to the European Union (AmChamEU), American European Community Association, Kangaroo Group, European Business Summit, Belgian Brain Council, ABC Global Alliance, Transforming Breast Cancer Together, Pharmaceutical Research and Manufacturers of America (PhRMA) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA).